🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- IPO
- 7/24/2026 · $15/share
Business: Scribe Therapeutics Inc is a clinical-stage biotechnology company engineering CRISPR-based technologies into purpose-built in vivo genetic medicines designed to become standard of care treatments for patients suffering from highly prevalent diseases, starting with cardiometabolic disease.
Company Contact
- CEO
- Benjamin L. Oakes
- CFO
- David L. Parrot
- Headquarters
- 1150 Marina Village Pkwy Alameda CA 94501
- Phone
- 510-454-0213
- Investor Relations
- ir@scribetx.com